Journal of Oral Implantology · 2013 · 56 citations · 28 references
DentistryMaxillofacial SurgeryOral SurgeryBone AugmentationBone GraftingImplant SurgeryOsteoporosisOsteoporosis PharmacotherapyBisphosphonate Therapy ManagementBisphosphonate-associated Jaw NecrosisEarly Implant PlacementImplant Survival AnalysisImplant Survival RatesOsseointegrationSurgical Implant PlacementTreatment With Bisphosphonates
The purposes of this preliminary study are to assess the risk of developing bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a patient with osteoporosis using zoledronic acid and to report the results of a 1-year prospective clinical study regarding 5 immediately inserted implants in the anterior mandible. For this comparative prospective study, 24 female patients, aged ≥54 years, were chosen, all with partially edentulous mandibles. Group A consisted of 12 patients with osteoporosis taking zoledronic acid receiving a once-yearly intravenous infusion of zoledronic acid (5 mg). Control group B consisted of 12 other patients without osteoporosis and not taking drugs. In both groups, the remaining teeth were extracted before 120 implants, 3.7-mm wide and 16-mm long, were immediately installed in the interforaminal region of the mandibles. The 1-year implant survival rate was 100%. No apparent necrotic bone was observed among patients receiving zoledronic acid (group A) after implant surgery. Immediate implant osseointegration can be successful in a patient with osteoporosis using bisphosphonates, suggesting the safety of implantology as a treatment modality.
28
Salvatore L. Ruggiero, Thomas B. Dodson, John E Fantasia et al. · Journal of Oral and Maxillofacial Surgery · 2014 · 2.9K citations